MBP metabolic pharmaceuticals limited

The osteoporosis out-licencing deal will be huge. This is...

  1. 498 Posts.
    The osteoporosis out-licencing deal will be huge. This is definitely a company that's going places. I'm not even factoring in the oral delivery technology. POH's patches are amusing, but a peptide pill would make this a $10 share overnight.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.